Literature DB >> 33587444

Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.

Oluwaseun Falade-Nwulia1, Eric C Seaberg1, Anna E Snider1, Charles R Rinaldo2, Steven M Wolinsky3, Mallory D Witt4, Chloe L Thio1.   

Abstract

Men with acute hepatitis B virus (HBV) infection in the Multicenter AIDS Cohort Study from 1985 to 2013 had serological testing to determine proportions with HBV recovery or chronic hepatitis B (CHB). A similar proportion of men without human immunodeficiency virus (HIV) and men with HIV receiving HBV-active antiretroviral therapy (ART) developed CHB [8.2%, 95% confidence interval (CI) 3.8-15.0% vs. 7.7%, 95% CI 2.00-36.0%]. In contrast, 17.5% (95% CI 8.7-29.9%) of men living with HIV, not on HBV-active ART developed CHB. HBV-active ART protects against developing CHB.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 33587444      PMCID： PMC8101059          DOI： 10.1097/QAD.0000000000002844

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.632


  9 in total

1.  The multicenter AIDS Cohort Study, 1983 to ….

Authors:  R Detels; L Jacobson; J Margolick; O Martinez-Maza; A Muñoz; J Phair; C Rinaldo; S Wolinsky
Journal:  Public Health       Date:  2011-12-27       Impact factor: 2.427

2.  The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state.

Authors:  N J Bodsworth; D A Cooper; B Donovan
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

3.  Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or Chronicity.

Authors:  Giulia Morsica; Laura Galli; Simona Bossolasco; Sabrina Bagaglio; Riccardo Vercesi; Stefania Salpietro; Hamid Hasson; Emanuela Messina; Antonella Castagna; Caterina Uberti-Foppa
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

4.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

5.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

Authors:  Chloe L Thio; Eric C Seaberg; Richard Skolasky; John Phair; Barbara Visscher; Alvaro Muñoz; David L Thomas
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

6.  Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.

Authors:  Helen M Chun; Ann M Fieberg; Katherine Huppler Hullsiek; Alan R Lifson; Nancy F Crum-Cianflone; Amy C Weintrob; Anuradha Ganesan; Robert V Barthel; William P Bradley; Brian K Agan; Michael L Landrum
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

7.  Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.

Authors:  Oluwaseun Falade-Nwulia; Eric C Seaberg; Anna E Snider; Charles R Rinaldo; John Phair; Mallory D Witt; Chloe L Thio
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

Review 8.  Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment.

Authors:  Chloe L Thio
Journal:  Semin Liver Dis       Date:  2003-05       Impact factor: 6.115

9.  Hepatitis B, hepatitis C, and mortality among HIV-positive individuals.

Authors:  Alicia C Thornton; Sophie Jose; Sanjay Bhagani; David Chadwick; David Dunn; Richard Gilson; Janice Main; Mark Nelson; Alison Rodger; Chris Taylor; Elaney Youssef; Clifford Leen; Mark Gompels; Stephen Kegg; Achim Schwenk; Caroline Sabin
Journal:  AIDS       Date:  2017-11-28       Impact factor: 4.177
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.